Innoviva Inc

INVA · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

88 USD

Margin of Safety

+74.6 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Innoviva Inc. is a healthcare holding company that primarily generates licensing fees from its stake in respiratory medications (particularly the GlaxoSmithKline partnership portfolio) as well as income from direct corporate investments in the biotechnology and pharmaceutical sectors.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.